117 related articles for article (PubMed ID: 12831591)
21. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
[TBL] [Abstract][Full Text] [Related]
22. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.
Wikland M; Bergh C; Borg K; Hillensjö T; Howles CM; Knutsson A; Nilsson L; Wood M
Hum Reprod; 2001 Aug; 16(8):1676-81. PubMed ID: 11473962
[TBL] [Abstract][Full Text] [Related]
23. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
Branigan EF; Estes MA
Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
[TBL] [Abstract][Full Text] [Related]
24. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial.
Cheung LP; Lam PM; Lok IH; Chiu TT; Yeung SY; Tjer CC; Haines CJ
Hum Reprod; 2005 Mar; 20(3):616-21. PubMed ID: 15608037
[TBL] [Abstract][Full Text] [Related]
25. Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study.
Ludwig M; Katalinic A; Banz C; Schröder AK; Löning M; Weiss JM; Diedrich K
Hum Reprod; 2002 Nov; 17(11):2842-5. PubMed ID: 12407036
[TBL] [Abstract][Full Text] [Related]
26. No influence of body weight on pregnancy rate in patients treated with cetrorelix according to the single- and multiple-dose protocols.
Engel JB; Ludwig M; Junge K; Howles CM; Diedrich K
Reprod Biomed Online; 2003 Jun; 6(4):482-7. PubMed ID: 12831598
[TBL] [Abstract][Full Text] [Related]
27. GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome.
Chang PL; Zeitoun KM; Chan LK; Thornton MH; Sauer MV
J Reprod Med; 2002 Apr; 47(4):253-8. PubMed ID: 12012875
[TBL] [Abstract][Full Text] [Related]
28. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Hwang JL; Seow KM; Lin YH; Huang LW; Hsieh BC; Tsai YL; Wu GJ; Huang SC; Chen CY; Chen PH; Tzeng CR
Hum Reprod; 2004 Sep; 19(9):1993-2000. PubMed ID: 15284212
[TBL] [Abstract][Full Text] [Related]
29. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
[TBL] [Abstract][Full Text] [Related]
30. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
32. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.
Hum Reprod; 1998 Nov; 13(11):3023-31. PubMed ID: 9853849
[TBL] [Abstract][Full Text] [Related]
34. Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).
Albano C; Smitz J; Camus M; Riethmüller-Winzen H; Siebert-Weigel M; Diedrich K; Van Steirteghem AC; Devroey P
Hum Reprod; 1996 Oct; 11(10):2114-8. PubMed ID: 8943511
[TBL] [Abstract][Full Text] [Related]
35. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
36. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
37. Clomiphene-induced LH surges and cetrorelix.
Engel JB; Felberbaum RE; Eilers W; Polack S; Ortmann O; Diedrich K
Reprod Biomed Online; 2002; 5(2):109-11. PubMed ID: 12419033
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation.
Tiboni GM; Palumbo P; Leonzio E; Gabriele E; Verna I; Giampietro F
Gynecol Endocrinol; 2011 Nov; 27(11):885-9. PubMed ID: 21500992
[TBL] [Abstract][Full Text] [Related]
39. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
Messinis IE; Templeton A; Baird DT
J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
[TBL] [Abstract][Full Text] [Related]
40. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.
Karimzadeh MA; Mashayekhy M; Mohammadian F; Moghaddam FM
Arch Gynecol Obstet; 2011 May; 283(5):1159-64. PubMed ID: 21221982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
